Herpesvirus trigger accelerates neuroinflammation in a nonhuman primate model of multiple sclerosis.
Emily C LeibovitchBreanna P CarusoSeung Kwon HaMatthew K SchindlerNathanael J LeeNicholas J LucianoBridgette J BilliouxJoseph R GuyCecil YenPascal SatiAfonso C SilvaDaniel S ReichSteven JacobsonPublished in: Proceedings of the National Academy of Sciences of the United States of America (2018)
Pathogens, particularly human herpesviruses (HHVs), are implicated as triggers of disease onset/progression in multiple sclerosis (MS) and other neuroinflammatory disorders. However, the time between viral acquisition in childhood and disease onset in adulthood complicates the study of this association. Using nonhuman primates, we demonstrate that intranasal inoculations with HHV-6A and HHV-6B accelerate an MS-like neuroinflammatory disease, experimental autoimmune encephalomyelitis (EAE). Although animals inoculated intranasally with HHV-6 (virus/EAE marmosets) were asymptomatic, they exhibited significantly accelerated clinical EAE compared with control animals. Expansion of a proinflammatory CD8 subset correlated with post-EAE survival in virus/EAE marmosets, suggesting that a peripheral (viral?) antigen-driven expansion may have occurred post-EAE induction. HHV-6 viral antigen in virus/EAE marmosets was markedly elevated and concentrated in brain lesions, similar to previously reported localizations of HHV-6 in MS brain lesions. Collectively, we demonstrate that asymptomatic intranasal viral acquisition accelerates subsequent neuroinflammation in a nonhuman primate model of MS.
Keyphrases
- multiple sclerosis
- white matter
- mass spectrometry
- sars cov
- ms ms
- cerebral ischemia
- traumatic brain injury
- endothelial cells
- lipopolysaccharide induced
- depressive symptoms
- lps induced
- early life
- blood brain barrier
- inflammatory response
- multidrug resistant
- pluripotent stem cells
- childhood cancer
- induced pluripotent stem cells
- free survival